Insider · CIK 0001416176

Varian John

Reports to the SEC for 6 companies · NEW YORK, NY

sec.gov

Transactions

Companies

Filings

CIK

0001416176

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-01-07	SLSSELLAS Life Sciences Group, Inc.A Award	Director	AAward	+50K sh	—	—	72,900
2025-01-10	SLSSELLAS Life Sciences Group, Inc.A Award	Director	AAward	+12.5K sh	—	—	22,900
2025-01-10	SLSSELLAS Life Sciences Group, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+18.5K sh	—	—	18,500
2024-01-22	SLSSELLAS Life Sciences Group, Inc.A Award	Director	AAward	+6,000 sh	—	—	10,400
2024-01-22	SLSSELLAS Life Sciences Group, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+10K sh	—	—	10,000
2023-06-22	Acorda Therapeutics, Inc.Non-Employee Stock OptionA Award	Director	AAward	+1,200 sh	—	—	1,200
2023-02-02	SLSSELLAS Life Sciences Group, Inc.A Award	Director	AAward	+2,500 sh	—	—	4,400
2023-02-02	SLSSELLAS Life Sciences Group, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+9,500 sh	—	—	9,500
2023-01-01	Acorda Therapeutics, Inc.Non-Employee Stock OptionA Award	Director	AAward	+4,712 sh	—	—	4,712
2022-01-31	SLSSELLAS Life Sciences Group, Inc.A Award	Director	AAward	+1,900 sh	—	—	1,900
2022-01-31	SLSSELLAS Life Sciences Group, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+7,125 sh	—	—	7,125
2022-01-01	Acorda Therapeutics, Inc.Non-Employee Stock OptionA Award	Director	AAward	+20K sh	—	—	20,000
2021-03-04	SLSSELLAS Life Sciences Group, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+7,500 sh	—	—	7,500
2020-03-12	SLSSELLAS Life Sciences Group, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+6,500 sh	—	—	6,500
2019-03-14	SLSSELLAS Life Sciences Group, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+25K sh	—	—	25,000
2019-01-31	Zyla Life SciencesStock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−110K sh	—	—	0
2018-07-02	Zyla Life SciencesStock Option (right to buy)A Award	Director	AAward	+110K sh	—	—	110,000
2018-06-12	SLSSELLAS Life Sciences Group, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+5,500 sh	—	—	5,500
2018-03-13	SLSSELLAS Life Sciences Group, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+11K sh	—	—	11,000
2017-12-20	Aravive, Inc.A Award	Director	AAward	+11.2K sh	—	—	22,280
2017-05-25	Aravive, Inc.A Award	Director	AAward	+3,480 sh	—	—	11,080
2017-05-25	Aravive, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+6,850 sh	—	—	6,850
2017-05-16	XOMA Royalty CorpS Sale	Director	SSale	−39.5K sh	$6.24	−$247K	2,344
2017-02-10	XOMA Royalty CorpNon-Qualified Share Option (right to buy)A Award	Director	AAward	+8,000 sh	—	—	8,000
2016-12-21	XOMA Royalty CorpS Sale	Director	SSale	−13.5K sh	$5.75	−$77.9K	41,884
2016-08-25	Aravive, Inc.S Sale	Director	SSale	−1,600 sh	$12.97	−$20.8K	7,600
2016-05-18	Aravive, Inc.A Award	Director	AAward	+4,625 sh	—	—	9,200
2016-05-18	Aravive, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+14.6K sh	—	—	14,625
2016-03-22	XOMA Royalty CorpS Sale	Director	SSale	−81K sh	$0.78	−$63.6K	1,108,673
2016-03-18	XOMA Royalty CorpM Exercise/Conversion	Director	MExercise/Conversion	+36.9K sh	—	—	1,189,695
2016-03-18	XOMA Royalty CorpRestricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−36.9K sh	—	—	0
2016-02-25	XOMA Royalty CorpA Award	Director	AAward	+542K sh	—	—	1,152,788
2015-12-31	XOMA Royalty CorpJ Other	Director	JOther	+8,721 sh	$1.38	+$12K	27,259
2015-08-14	XOMA Royalty CorpD Disposition to Issuer	Director	DDisposition to Issuer	−35.8K sh	$0.83	−$29.8K	516,615
2015-08-14	XOMA Royalty CorpM Exercise/Conversion	Director	MExercise/Conversion	+94.6K sh	—	—	611,188
2015-08-14	XOMA Royalty CorpRestricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−94.6K sh	—	—	195,239
2015-07-15	XOMA Royalty CorpM Exercise/Conversion	Director	MExercise/Conversion	+10K sh	$1.24	+$12.4K	562,414
2015-07-15	XOMA Royalty CorpS Sale	Director	SSale	−10K sh	$4.49	−$44.9K	552,414
2015-07-15	XOMA Royalty CorpIncentive Share Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−10K sh	$1.24	−$12.4K	70,392
2015-06-29	Aravive, Inc.A Award	Director	AAward	+4,575 sh	—	—	4,575
2015-06-29	Aravive, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+13.1K sh	—	—	13,100
2015-06-15	XOMA Royalty CorpM Exercise/Conversion	Director	MExercise/Conversion	+10K sh	$1.24	+$12.4K	562,414
2015-06-15	XOMA Royalty CorpS Sale	Director	SSale	−10K sh	$3.64	−$36.4K	552,414
2015-06-15	XOMA Royalty CorpIncentive Share Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−10K sh	$1.24	−$12.4K	80,392
2015-05-15	XOMA Royalty CorpM Exercise/Conversion	Director	MExercise/Conversion	+10K sh	$1.24	+$12.4K	562,414
2015-05-15	XOMA Royalty CorpS Sale	Director	SSale	−10K sh	$3.34	−$33.4K	552,414
2015-05-15	XOMA Royalty CorpIncentive Share Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−10K sh	$1.24	−$12.4K	90,392
2015-04-15	XOMA Royalty CorpM Exercise/Conversion	Director	MExercise/Conversion	+10K sh	$1.24	+$12.4K	562,414
2015-04-15	XOMA Royalty CorpS Sale	Director	SSale	−10K sh	$3.86	−$38.6K	552,414
2015-04-15	XOMA Royalty CorpIncentive Share Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−10K sh	$1.24	−$12.4K	100,392

Recent filings

Accepted (ET)
Jan 94
Varian John0001104659-26-002515
SEC(opens sec.gov)
Jan 144
Varian John0001104659-25-003495
SEC(opens sec.gov)
Jan 254
Varian John0001104659-24-006392
SEC(opens sec.gov)
Jun 234
Varian John0001209191-23-039483
SEC(opens sec.gov)
Feb 34
Varian John0001104659-23-010635
SEC(opens sec.gov)
Jan 44
Varian John0001209191-23-000518
SEC(opens sec.gov)
Feb 14
Varian John0001104659-22-010399
SEC(opens sec.gov)
Jan 44
Varian John0001209191-22-000750
SEC(opens sec.gov)
Mar 84
Varian John0001104659-21-033300
SEC(opens sec.gov)
Mar 164
Varian John0001104659-20-034289
SEC(opens sec.gov)
Mar 184
Varian John0000899243-19-008198
SEC(opens sec.gov)
Feb 44
Varian John0001179110-19-001263
SEC(opens sec.gov)
Jul 24
Varian John0001179110-18-009210
SEC(opens sec.gov)
Jun 134
Varian John0001209191-18-037554
SEC(opens sec.gov)
Mar 154
Varian John0001209191-18-020020
SEC(opens sec.gov)
Dec 224
Varian John0001209191-17-067113
SEC(opens sec.gov)

Companies

Address

C/O SELLAS LIFE SCIENCES GROUP, INC., 7 TIMES SQUARE, SUITE 2503

NEW YORK, NY, 10036